Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Core Insights - Adaptive Biotechnologies Corporation is participating in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York, highlighting its ongoing engagement with the investment community [1][2]. Company Overview - Adaptive Biotechnologies is a commercial-stage biotechnology company focused on leveraging the adaptive immune system for disease diagnosis and treatment. The company aims to decode the adaptive immune system's genetics to enhance medical capabilities [3]. - The company operates two business segments: Minimal Residual Disease (MRD) and Immune Medicine, developing clinical diagnostics and therapeutic products for diseases such as cancer and autoimmune disorders [3]. Upcoming Events - Management is scheduled for a fireside chat on September 10 at 10:05 a.m. Pacific Time, with a live and archived webcast available on the company's website [2].